Report Store Get Proposal

Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!

Home Blog Cardiovascular diseases 14

Cardiovascular Diseases

Pharma News for Aktis, Alcon and Takeda

Notizia - Recent Pharma, Healthcare and Biotech Happenings

Aktis’s Novel Targeted Alpha Radiopharmaceuticals; Koye Partners with Sonde Health; Novartis to Spin Off Sandoz Business; Alcon to Buy Aerie Pharma; Fast Track Designation to Merck’s MK-2060; FDA Approves Ibrutinib for Chronic GvHD; French Authorities Clears BrainVectis’s Clinical Trial; Takeda’s Dengue Vaccine TAK-003 Gets Approval in Indonesia

Aktis Oncology Raises USD 84 Million To Advance Novel Targeted Alpha Radiopharmaceuticals Aktis Oncology has raised an additional USD 84 million in its Series A round, adding to the USD 72 million raised last year to help bring its radiopharmaceuticals to market. The extension to the first round included Merck's venture capital arm and other investors (BMS and Novartis were already on board), bringing the total raised by the Massachusetts biotech to USD 161 million. To deliver highly localized radiotherapy to tumors, Aktis' technology platform employs alpha radiation, which has limited penetrating power. The company's drugs are designed to target receptors on tu...

Explore More...

pharma-news

Mavacamten Phase III clinical trial, FDA nod for Ovarian cancer therapy, Dyno Therapeutics & Novartis Collaboration, Abbott’s COVID-19 diagnostic kit

Telemedicine

Telemedicine: Can it be the future of healthcare?

pharma news

Ofev’s expanded use; Arkin Bio-Ventures II launch; USD 125 M for COVID-19 treatment

healthcare innovations

Top healthcare innovations changing the healthcare dynamics

Healthcare scenario in MENA region

Booming Healthcare sector in MENA: Lucrative opportunity for Global pharma players

Cardiovascular Disease

Cardiovascular Disease: A major cause of health loss and a global burden

Digital therapeutics

Potential of Digital therapeutics and increasing CVDs

Pharma News

Acceleron Pharma’s drug sotatercept touches the phase 2 mark; GT Medical receives nod for GammaTile; New treatment strategy for Parkinson’s disease

Pharma News

Tepezza receives approval; a new way to treat Alzheimer’s

polypills

Polypills: Can they offer a potential approach to treat CVDs?

Ischemia treatment market

Reversing Ischemia with Gene therapy

Pharma news

FDA approval to AZ’s Farxiga for heart failure; GSK divests two travel vaccines to Bavarian Nordic; New breakthrough therapy for Cystic Fibrosis

Systemic sclerosis

FDA approves Ofev for interstitial lung disease

Pharma News

Helsinn out licenses Pracinostat in South America

Pharma News

Juvenescence nets USD 100M; Sarepta DMD drug faces rejection

Recent Pharma News

Recursion Pharmaceuticals nets USD 121M; Bayer’s MRI agent gets a nod

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Daily

Weekly

Monthly